<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To discover the prevalence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in women with a history of repeated <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriages</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Therapy evaluation of aspirin and <z:chebi fb="0" ids="8382">prednisone</z:chebi> to achieve living term foetus from women in whom <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> had been detected and who had become pregnant again </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHODS: 82 consecutive women with history of at least of two <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriages</z:e>, with no live foetus in either case </plain></SENT>
<SENT sid="3" pm="."><plain>14 women positive for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> who had become pregnant again (group of therapy evaluation), were treated with aspirin (125 mg/d) and <z:chebi fb="0" ids="8382">prednisone</z:chebi> (20 mg/d) </plain></SENT>
<SENT sid="4" pm="."><plain>60 <z:mpath ids='MPATH_458'>normal</z:mpath> pregnant women (control group) </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> evaluation: APTT tests caolin clotting time and APTT system neutralized with platelet <z:chebi fb="1" ids="16247">phospholipids</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo>: ELISA test </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: 13.4% were positive to <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (ELISA), and 2.4% were positive in both positive in both test </plain></SENT>
<SENT sid="8" pm="."><plain>Therapy evaluation: 75.5% (11 cases) of pregnancies were successful (<z:mpath ids='MPATH_458'>normal</z:mpath> foetus), 14% (2 cases) of fetal losses, and 7% (1 case) of foetal malformations (acranius) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: In our study the <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> represent one of the main causes of repeated foetal losses </plain></SENT>
<SENT sid="10" pm="."><plain>We recommended in cases of <z:mp ids='MP_0001924'>infertile</z:mp> women to test for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> regularly </plain></SENT>
<SENT sid="11" pm="."><plain>We confirm the effectiveness of the therapy (aspirin and <z:chebi fb="0" ids="8382">prednisone</z:chebi>) in achieving successful pregnancies in patients with a history of <z:hpo ids='HP_0000789'>infertility</z:hpo> </plain></SENT>
</text></document>